Plus therapeutics to present at the 2nd annual targeted radiopharmaceuticals summit

Austin, texas, july 13, 2023 (globe newswire) -- plus therapeutics, inc. (nasdaq:  pstv ) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that marc hedrick, m.d., president and chief executive officer, will give two presentations at the targeted radiopharmaceuticals summit taking place july 25-27, 2023 in boston, massachusetts.
pstv Ratings Summary
pstv Quant Ranking